Washington Trust Bank’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.84M Sell
7,304
-5,155
-41% -$1.11M 0.13% 94
2026
Q1
$2.71M Buy
12,459
+578
+5% +$128K 0.2% 71
2025
Q4
$2.71M Buy
11,881
+221
+2% +$50.3K 0.19% 72
2025
Q3
$2.7M Buy
11,660
+903
+8% +$184K 0.2% 65
2025
Q2
$2M Sell
10,757
-450
-4% -$83.6K 0.17% 80
2025
Q1
$2.35M Sell
11,207
-2,895
-21% -$563K 0.24% 67
2024
Q4
$2.51M Sell
14,102
-20
-0.1% -$3.68K 0.24% 66
2024
Q3
$2.79M Sell
14,122
-278
-2% -$51.9K 0.27% 63
2024
Q2
$2.47M Sell
14,400
-470
-3% -$77.9K 0.24% 62
2024
Q1
$2.71M Sell
14,870
-7,663
-34% -$1.32M 0.26% 65
2023
Q4
$3.49M Sell
22,533
-78
-0.3% -$11.4K 0.31% 64
2023
Q3
$3.37M Buy
22,611
+6,406
+40% +$940K 0.35% 59
2023
Q2
$2.18M Sell
16,205
-719
-4% -$105K 0.22% 64
2023
Q1
$2.7M Sell
16,924
-630
-4% -$96.3K 0.29% 63
2022
Q4
$2.84M Buy
17,554
+333
+2% +$51.1K 0.32% 67
2022
Q3
$2.31M Sell
17,221
-891
-5% -$128K 0.29% 72
2022
Q2
$2.77M Sell
18,112
-1,045
-5% -$160K 0.36% 62
2022
Q1
$3.1M Sell
19,157
-5,601
-23% -$814K 0.36% 59
2021
Q4
$3.35M Sell
24,758
-3,293
-12% -$389K 0.32% 56
2021
Q3
$3.03M Sell
28,051
-2,840
-9% -$325K 0.35% 53
2021
Q2
$3.48M Sell
30,891
-1,027
-3% -$116K 0.41% 51
2021
Q1
$3.45M Sell
31,918
-85,795
-73% -$9.18M 0.43% 50
2020
Q4
$12.6M Buy
117,713
+1,420
+1% +$136K 1.65% 13
2020
Q3
$10.2M Sell
116,293
-2,589
-2% -$244K 1.51% 13
2020
Q2
$11.7M Buy
118,882
+74
+0.1% +$6.51K 1.86% 7
2020
Q1
$9.05M Buy
118,808
+5,697
+5% +$485K 1.74% 9
2019
Q4
$10M Sell
113,111
-2,308
-2% -$192K 1.42% 14
2019
Q3
$8.74M Buy
115,419
+4,058
+4% +$278K 1.43% 17
2019
Q2
$8.1M Buy
111,361
+1,293
+1% +$102K 1.32% 21
2019
Q1
$8.87M Buy
110,068
+9,176
+9% +$751K 1.41% 17
2018
Q4
$9.3M Buy
100,892
+23
+0% +$2.02K 1.22% 18
2018
Q3
$9.54M Sell
100,869
-5,353
-5% -$508K 1.42% 12
2018
Q2
$9.84M Sell
106,222
-2,004
-2% -$196K 1.37% 13
2018
Q1
$10.2M Sell
108,226
-9,288
-8% -$1.02M 1.47% 9
2017
Q4
$11.4M Sell
117,514
-963
-0.8% -$90.8K 1.66% 7
2017
Q3
$10.5M Buy
118,477
+63,189
+114% +$4.81M 1.67% 7
2017
Q2
$4.01M Buy
55,288
+597
+1% +$40.1K 0.86% 26
2017
Q1
$3.56M Buy
54,691
+967
+2% +$60.8K 0.77% 27
2016
Q4
$3.36M Sell
53,724
-916
-2% -$55.9K 0.76% 25
2016
Q3
$3.45M Sell
54,640
-135
-0.2% -$8.74K 0.83% 24
2016
Q2
$3.39M Buy
54,775
+2,944
+6% +$179K 0.88% 25
2016
Q1
$2.96M Buy
51,831
+3,802
+8% +$212K 0.77% 29
2015
Q4
$2.85M Sell
48,029
-2,298
-5% -$132K 0.62% 37
2015
Q3
$2.74M Sell
50,327
-473
-0.9% -$30.8K 0.73% 25
2015
Q2
$3.41M Buy
50,800
+1,250
+3% +$81.6K 0.83% 20
2015
Q1
$2.9M Buy
49,550
+5,009
+11% +$303K 0.7% 23
2014
Q4
$2.92M Buy
44,541
+2,851
+7% +$180K 0.76% 26
2014
Q3
$2.41M Sell
41,690
-78,098
-65% -$4.34M 0.76% 23
2014
Q2
$6.76M Sell
119,788
-2,451
-2% -$129K 1.37% 11
2014
Q1
$6.28M Buy
+122,239
New +$6.18M 1.33% 13
2013
Q4
Sell
-105,546
Closed -$5.19M 150
2013
Q3
$4.72M Buy
105,546
+45,469
+76% +$2.02M 1.23% 18
2013
Q2
$2.48M Buy
+60,077
New +$2.63M 0.72% 56

Other funds holding ABBV

Washington Trust Bank's ABBV Position: Q2 2026 in Review

Washington Trust Bank reduced its AbbVie (ABBV) stake by 41% in Q2 2026, selling an estimated $1.11M and leaving 7,304 shares worth $1.84M. The position accounts for 0.13% of the portfolio, ranked #94.

Washington Trust Bank first reported a position in ABBV in Q2 2013 and has held it in 52 quarters since. The position peaked at $12.6M in Q4 2020. 4,201 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Washington Trust Bank held 7,304 shares of AbbVie worth $1.84M as of Q2 2026.
  • Washington Trust Bank sold 5,155 AbbVie shares in Q2 2026, an estimated $1.11M.
  • AbbVie made up 0.13% of Washington Trust Bank's portfolio in Q2 2026, its #94 holding.
  • Washington Trust Bank first reported a position in AbbVie in Q2 2013 and has held it in 52 quarters since.
  • Washington Trust Bank's AbbVie position peaked at $12.6M in Q4 2020.
  • 4,201 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Washington Trust Bank's 13F filing for Q2 2026, filed 5 Aug 2026.